American eagle application formc

The Sorcery Lineage of Don Juan Matus & Carlos Castaneda

2011.02.11 22:05 The Sorcery Lineage of Don Juan Matus & Carlos Castaneda

The purpose of this subreddit is to aid in the pragmatic application of the works of Carlos Castaneda, Florinda Donner, Taisha Abelar, & Carol Tiggs to how we experience existence. Core topics include: sorcery (a.k.a. the mastery of intent), awareness, & non-ordinary reality (magic). Here, you can: learn ABOUT sorcery, what has and has not worked over thousands of years, decide to empirically embark on your own "definitive journey," and altruistically document your challenges and discoveries.
[link]


2024.05.17 10:43 prajnene Cloud Seeding Market Size Trends, Growth, and Competitive Landscape

The global cloud seeding market size is set to gain traction from the increasing adoption of weather modification technologies by various countries, shares Fortune Business Insights™ in its report, titled ”Cloud Seeding Market Size, 2024-2032”.
The cloud seeding market is witnessing significant growth, driven by advancements in weather modification technologies and increasing concerns about water scarcity. As climate change intensifies drought conditions in various regions, governments and private sectors are investing in cloud seeding to enhance precipitation. Innovations in seeding agents, coupled with improved weather forecasting models, are making cloud seeding more efficient and cost-effective. This trend is particularly strong in agriculture-dependent economies and regions prone to wildfires, where boosting rainfall can mitigate risks and enhance crop yields. The market is poised for robust expansion as sustainability and resource management take center stage globally.
Browse In-depth Summary of This Research Insight:
https://www.fortunebusinessinsights.com/cloud-seeding-market-104073
~Segmentation- Cloud Seeding Market Size~
Based on type, the market is segmented into the ground and aerial-based seeding. In terms of method, the market has been segregated into dynamic cloud seeding and hygroscopic cloud seeding. By geography, the market has been categorized into North America, Europe, Asia Pacific, and the Rest of the World.
List of Key Players Profiled in the Cloud Seeding Market Report
~Report Highlights~
This report encompasses an in-depth evaluation of the factors driving and constraining the cloud seeding market Size and also contains a piecemeal study of the different segments of the market. Further, it also supplies a careful examination of the competitive landscape of the market, besides incorporating a detailed analysis of the regional trends and prospects in the market.
~Drivers & Restraints-~
Mounting Concerns over Water Scarcity Worldwide to Favor the Market
Water scarcity has become an acute concern for large swathes of the human population. According to a 2018 report by the UN, more than 2 billion people around the globe are undergoing extreme water distress. A 2020 report by the Food and Agriculture Organization (FAO) revealed that 3.2 billion people reside in agricultural areas with high to very high water shortages. The growing water crisis across the planet has, therefore, created a dire need for weather technologies that can replenish depleted natural water reserves and build water sufficiency in vulnerable regions. Cloud seeding systems can play a vital role in meeting these challenges, as these technologies can stimulate artificial rain and expand access to usable water in water-constrained regions. Such technologies can be particularly useful in desert regions, such as the Middle East and Northern African countries. For example, at the Khalifa University of Science and Technology, UAE, researchers are testing nanotechnology-based cloud seeding materials that can significantly increase the size of rain droplets and make them denser.
~Regional Insights- Cloud Seeding Market Size~
Rising Trend of Technological Advancements to Boost Market Growth in North America
North America will have the largest cloud seeding market share due to high technological advancements in climate control systems. In North America, the use of climate modifying solutions for communication and surveillance is also driving market development.
Europe is also expected to have a healthy growth rate in this sector, as countries in the region are making concerted efforts to reduce their reliance on erratic rains and develop their own "rain cycles." The market in Asia Pacific, on the other hand, is expected to expand due to the various rain-inducing programs undertaken by regional governments, as well as increased demand for commercial applications.
~Competitive Landscape-~
Government Programs to Promote Cloud Seeding in Arid Areas to Encourage Innovation
Government initiatives, such as increasing the implementation of artificial rainfall technologies to improve water levels in countries such as India, are expected to drive the demand for weather control equipment. Furthermore, governments in India, the United Arab Emirates, and China are investing heavily in weather modification activities, generating huge opportunities for research and innovation for market players.
~Industry Development-~
July 2020: The National Center of Meteorology (NCM), UAE, declared that it had executed 219 cloud seeding operations across the country, using over 4,500 flares manufactured by the NCM's Weather Enhancement Plant.
submitted by prajnene to u/prajnene [link] [comments]


2024.05.17 10:27 utherpharmaceutical about semaglutide

about semaglutide
Novo Nordisk recently announced the latest results of the STEP Phase 3a clinical trial project of semaglutide (semaglutide) 2.4 mg subcutaneous injection preparation for the treatment of obesity at the 2021 American Endocrine Society (ENDO 2021) Annual Meeting. Data from the STEP 4 trial showed that treatment with once-weekly subcutaneous (SC) 2.4 mg dose of semaglutide resulted in statistically significant weight reductions compared with placebo.
Obesity is a chronic disease that requires long-term treatment and is associated with many serious health consequences and reduced life expectancy. There are many complications associated with obesity, including type 2 diabetes, heart disease, obstructive sleep apnea, chronic kidney disease, non-alcoholic fatty liver disease and cancer.
Novo Nordisk is currently developing a once-weekly 2.4 mg subcutaneous formulation of semaglutide as a treatment for obesity in adults. Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that can help people eat less, reduce calorie intake, and induce weight loss by reducing hunger and increasing satiety.
The STEP program (Semaglutide in Obesity) is a global Phase IIIa clinical development program evaluating a once-weekly subcutaneous (SC) 2.4 mg dose of semaglutide for weight management in adults with obesity. The project includes a total of 4 phase IIIa trials, which have enrolled approximately 4,500 overweight or obese adults, and all trials have been successful.
Based on data from the STEP clinical project, Novo Nordisk submitted a New Drug Application (NDA) for semaglutide 2.4mg subcutaneous injection to the US FDA in December 2020. The drug is injected subcutaneously once a week for long-term weight management. It is worth mentioning that Novo Nordisk also submitted a Priority Review Voucher (PRV) to speed up the NDA review. This PRV can shorten the NDA review cycle from the standard 10 months to 6 months.
The indications applied for for semaglutide 2.4 mg subcutaneous injection preparation are: as an adjunct to a low-calorie diet and increased exercise, for the treatment of obesity (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27 kg/m2) accompanied by at least one body weight Adult patients with relevant comorbidities.
STEP 4 (withdrawal) was a 68-week, randomized, double-blind, multicenter, placebo-controlled, withdrawal trial comparing semaglutide to placebo in 902 obese or overweight patients with comorbidities Efficacy and safety for sustained weight management. The trial includes a 20-week run-in period and a 48-week maintenance period. During the 20-week lead-in period, after receiving dose-escalating semaglutide treatment, 803 patients reached the target dose of 2.4 mg, and their average weight decreased from 107.2 kg to 96.1 kg. After that, these patients entered the maintenance phase and were randomly divided into 2 groups, one group received SC semaglutide 2.4 mg once a week, and the other group received SC placebo once a week for 48 weeks. Throughout the study, both treatment groups followed a regimen of low-calorie diet and increased physical activity.
The trial used 2 statistical methods: (1) based on treatment strategy evaluation (primary statistical method), that is, without considering treatment compliance or the therapeutic effect of using other weight loss drugs; (2) based on trial product evaluation (secondary statistical method) ), that is, all patients adhere to the study drug treatment and do not use other weight loss drugs.
The results showed that the STEP 4 trial met the two primary endpoints, and the data had statistically significant differences, showing that patients who continued to receive SC semaglutide 2.4mg further lost weight significantly, while patients who switched to placebo significantly regained their weight.
——The main statistical method showed that among all randomized patients, those who continued to receive SC semaglutide 2.4 mg for 48 weeks continued to reduce the average body weight by 7.9% from the baseline at randomization (weight at the end of the run-in period); while those who received placebo For patients, mean weight increased by 6.9% from baseline at randomization. The treatment difference between the 2 groups was statistically significant. Patients who received once-weekly SC semaglutide for 68 weeks (20-week lead-in period + 48-week maintenance period) experienced an average weight loss of 17.4%.
——Secondary statistical methods showed that among intention-to-treat patients, patients who continued to receive SC semaglutide 2.4 mg for 48 weeks continued to reduce mean body weight by 8.8% from baseline at randomization (weight at the end of the run-in period); For placebo patients, mean weight increased by 6.5% from baseline at randomization. The treatment difference between the 2 groups was statistically significant. Patients who received weekly SC semaglutide for 68 weeks experienced an average weight loss of 18.2%.
In this trial, the safety profile of once-weekly subcutaneous injection of semaglutide 2.4 mg was consistent with that previously observed for GLP-1 receptor agonists and was well tolerated. The most common adverse events in patients treated with semaglutide 2.4 mg were gastrointestinal events.
submitted by utherpharmaceutical to FastingtoLoseWeight [link] [comments]


2024.05.17 09:37 rxhix american express referral $200 bonus cash back plus an extra $15

hi guys! i have 12 american express referral offers available where you can earn $200 bonus cash back (after spending $2000 in first 6 months).
besides that, i’ll send you $15 as soon as i see your application approval bonus post on my statement. please apply using my link below!
https://americanexpress.com/en-us/referral/blue-cash-everyday-credit-card?ref=ROHIZGiUE&XL=MIMNS
submitted by rxhix to referralcodes [link] [comments]


2024.05.17 09:33 Torre_Nera Experiment #025613 - My investment journey

Start date: May 15, 2024.
Total investment: € 9996.59.
Total current return: € ? (?%).
Next update: May 23, 2024.
End date: December 31, 2024.
Here is the .csv file:
Broker ticker,YF ticker,Listing country,Name,Currency,Type,Exchange,Sector,Industry,Last date (YYYY-MM-DD),Last price,Last price (EUR),Purchase date (YYYY-MM-DD),Purchase price,Purchase price (EUR),Quantity,Total cost,Total cost (EUR),Stop loss,Stop loss (EUR) 4BB.L,4BB.L,GB,4basebio PLC,GBp,EQUITY,LSE,Healthcare,Biotechnology,2024-05-15,1410,16.4411112956747,2024-05-15,1410,16.4411112956747,6,8460,98.6466677740485,181.99237928413,2.12076386322516 ABBN.VX,ABBN.SW,CH,ABB Ltd,CHF,EQUITY,EBS,Industrials,Electrical Equipment & Parts,2024-05-15,48.2000007629395,49.2463076080989,2024-05-15,48.2000007629395,49.2463076080989,2,96.4000015258789,98.4926152161979,30.0463815309176,30.6219409984699 ACGL.O,ACGL,US,Arch Capital Group Ltd.,USD,EQUITY,NMS,Financial Services,Insurance - Diversified,2024-05-15,97.8700027465821,90.0003736957321,2024-05-15,97.8700027465821,90.0003736957321,1,97.8700027465821,90.0003736957321,57.6807854724479,53.0540366273465 ADMA.O,ADMA,US,"ADMA Biologics, Inc.",USD,EQUITY,NGM,Healthcare,Biotechnology,2024-05-15,9.10000038146973,8.36827845079613,2024-05-15,9.10000038146973,8.36827845079613,12,109.200004577637,100.419341409554,1.47446989649493,1.35619824268739 AET.L,AET.L,GB,Afentra plc,GBp,EQUITY,LSE,Energy,Oil & Gas E&P,2024-05-15,51.5999984741211,0.601674693453668,2024-05-15,51.5999984741211,0.601674693453668,166,8565.5997467041,99.8779991133089,17.2552084436733,0.201075576151617 ALDNX.PAR,ALDNX.PA,FR,DNXCorp SE,EUR,EQUITY,PAR,Communication Services,Internet Content & Information,2024-05-15,22,22,2024-05-15,22,22,5,110,110,11.1928169792181,11.1928169792181 ALLAN.PAR,ALLAN.PA,FR,Lanson-BCC,EUR,EQUITY,PAR,Consumer Defensive,Beverages - Wineries & Distilleries,2024-05-15,46.5999984741211,46.5999984741211,2024-05-15,46.5999984741211,46.5999984741211,2,93.1999969482422,93.1999969482422,33.9247673647968,33.9247673647968 ALLOG.PAR,ALLOG.PA,FR,Logic Instrument S.A.,EUR,EQUITY,PAR,Technology,Computer Hardware,2024-05-15,1.16499996185303,1.16499996185303,2024-05-15,1.16499996185303,1.16499996185303,86,100.18999671936,100.18999671936,0.369989265252377,0.369989265252377 AROC.N,AROC,US,"Archrock, Inc.",USD,EQUITY,NYQ,Energy,Oil & Gas Equipment & Services,2024-05-15,20,18.39182,2024-05-15,20,18.39182,5,100,91.9591,9.52721949298871,8.76301263579761 ARRWU.O,ARRWU,US,Arrowroot Acquisition Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-04-16,17,15.633047,2024-04-16,17,15.633047,6,102,93.798282,8.8489792646162,8.13917609086355 ARYD.O,ARYD,US,ARYA Sciences Acquisition Corp IV,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.3699998855591,10.4557495647612,2024-05-15,11.3699998855591,10.4557495647612,10,113.699998855591,104.557495647612,10.6225484108966,9.77048193521333 BA_.L,BA.L,GB,BAE Systems plc,GBp,EQUITY,LSE,Industrials,Aerospace & Defense,2024-05-15,1363,15.8930742524856,2024-05-15,1363,15.8930742524856,6,8178,95.3584455149135,816.219675877841,9.51143778582399 BDB.MI,BDB.MI,IT,Banco di Desio e della Brianza S.p.A.,EUR,EQUITY,MIL,Financial Services,Banks—Regional,2024-05-15,4.98000001907349,4.98000001907349,2024-05-15,4.98000001907349,4.98000001907349,20,99.6000003814697,99.6000003814697,3.15504560196379,3.15504560196379 BDT.TO,BDT.TO,CA,Bird Construction Inc.,CAD,EQUITY,TOR,Industrials,Engineering & Construction,2024-05-15,22.5100002288818,15.1999072001158,2024-05-15,22.5100002288818,15.1999072001158,7,157.570001602173,106.39935040081,7.03762236613261,4.74895717230204 BPE.MI,BPE.MI,IT,BPER Banca SpA,EUR,EQUITY,MIL,Financial Services,Banks—Regional,2024-05-15,5.01200008392334,5.01200008392334,2024-05-15,5.01200008392334,5.01200008392334,20,100.240001678467,100.240001678467,2.09752578063009,2.09752578063009 BPSO.MI,BPSO.MI,IT,Banca Popolare di Sondrio S.p.A,EUR,EQUITY,MIL,Financial Services,Banks—Regional,2024-05-15,8.1899995803833,8.1899995803833,2024-05-15,8.1899995803833,8.1899995803833,12,98.2799949645996,98.2799949645996,3.57230683027942,3.57230683027942 BRBR.N,BRBR,US,"BellRing Brands, Inc.",USD,EQUITY,NYQ,Consumer Defensive,Packaged Foods,2024-05-15,58.9000015258789,54.1639113031845,2024-05-15,58.9000015258789,54.1639113031845,2,117.800003051758,108.327822606369,29.9543368800174,27.5516096558606 CAMT.O,CAMT,US,Camtek Ltd.,USD,EQUITY,NGM,Technology,Semiconductor Equipment & Materials,2024-05-15,100.389999389648,92.3177399287262,2024-05-15,100.389999389648,92.3177399287262,1,100.389999389648,92.3177399287262,13.0355686283783,11.9899465619902 CECO.O,CECO,US,CECO Environmental Corp.,USD,EQUITY,NMS,Industrials,Pollution & Treatment Controls,2024-05-15,25.1200008392334,23.1001266917515,2024-05-15,25.1200008392334,23.1001266917515,4,100.480003356934,92.4005067670059,9.5891733627488,8.81999699980263 CEU.TO,CEU.TO,CA,CES Energy Solutions Corp.,CAD,EQUITY,TOR,Energy,Oil & Gas Equipment & Services,2024-05-15,6.88000011444092,4.64572910763949,2024-05-15,6.88000011444092,4.64572910763949,22,151.3600025177,102.206040368069,1.86502711047414,1.25851223780441 CHG.FRA,CHG.F,DE,CHAPTERS Group AG,EUR,EQUITY,FRA,Technology,Information Technology Services,2024-05-15,23.2000007629395,23.2000007629395,2024-05-15,23.2000007629395,23.2000007629395,4,92.8000030517578,92.8000030517578,9.6013365799341,9.6013365799341 CIRC.MI,CIRC.MI,IT,Circle S.p.A.,EUR,EQUITY,MIL,Technology,Information Technology Services,2024-05-15,6.8600001335144,6.8600001335144,2024-05-15,6.8600001335144,6.8600001335144,15,102.900002002716,102.900002002716,4.30242335652391,4.30242335652391 CLS.TO,CLS.TO,CA,Celestica Inc.,CAD,EQUITY,TOR,Technology,Electronic Components,2024-05-15,70.8000030517578,47.8077949894401,2024-05-15,70.8000030517578,47.8077949894401,2,141.600006103516,95.6155899788802,3.54000015258789,2.38877681125436 COH.PAR,COH.PA,FR,Coheris SA,EUR,EQUITY,PAR,Technology,Software—Application,2024-05-15,6.73999977111816,6.73999977111816,2024-05-15,6.73999977111816,6.73999977111816,15,101.099996566772,101.099996566772,2.88333012866946,2.88333012866946 COOL.O,COOL,US,Corner Growth Acquisition Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.3699998855591,10.4557495647612,2024-05-15,11.3699998855591,10.4557495647612,10,113.699998855591,104.557495647612,10.3322166375254,9.5034385443796 CPH.TO,CPH.TO,CA,Cipher Pharmaceuticals Inc.,CAD,EQUITY,TOR,Healthcare,Drug Manufacturers—Specialty & Generic,2024-05-15,8.78999996185303,5.93545901158012,2024-05-15,8.78999996185303,5.93545901158012,17,149.429999351501,100.902803196862,1.96204830367043,1.32398171987155 CPRT.O,CPRT,US,"Copart, Inc.",USD,EQUITY,NMS,Industrials,Specialty Business Services,2024-05-15,55.310001373291,50.8625794728661,2024-05-15,55.310001373291,50.8625794728661,2,110.620002746582,101.725158945732,35.3170907446316,32.4842009447324 CRS.N,CRS,US,Carpenter Technology Corporation,USD,EQUITY,NYQ,Industrials,Metal Fabrication,2024-05-15,109.550003051758,100.741196856369,2024-05-15,109.550003051758,100.741196856369,1,109.550003051758,100.741196856369,34.0476120260581,31.3165509226119 DIS.MI,DIS.MI,IT,d'Amico International Shipping S.A.,EUR,EQUITY,MIL,Industrials,Marine Shipping,2024-05-15,7.69999980926514,7.69999980926514,2024-05-15,7.69999980926514,7.69999980926514,13,100.099997520447,100.099997520447,1.48521744342503,1.48521744342503 DNG.TO,DNG.TO,CA,Dynacor Group Inc.,CAD,EQUITY,TOR,Basic Materials,Other Precious Metals & Mining,2024-05-15,5.42000007629395,3.65986216555364,2024-05-15,5.42000007629395,3.65986216555364,27,146.340002059937,98.8162784699483,2.73996555376442,1.8489169198717 DRX.TO,DRX.TO,CA,ADF Group Inc.,CAD,EQUITY,TOR,Industrials,Metal Fabrication,2024-05-15,16.3299999237061,11.0268538824693,2024-05-15,16.3299999237061,11.0268538824693,9,146.969999313355,99.2416849422234,0.816499996185303,0.550970670396969 E.TO,E.TO,CA,"Enterprise Group, Inc.",CAD,EQUITY,TOR,Energy,Oil & Gas Equipment & Services,2024-05-15,1.21000003814697,0.817054113947654,2024-05-15,1.21000003814697,0.817054113947654,122,147.620004653931,99.6806019016138,0.210420134172571,0.141990597589385 ENO.MC,ENO.MC,ES,"Elecnor, S.A.",EUR,EQUITY,MCE,Industrials,Infrastructure Operations,2024-05-15,21.2000007629395,21.2000007629395,2024-05-15,21.2000007629395,21.2000007629395,5,106.000003814697,106.000003814697,12.551528826266,12.551528826266 ENVI.AS,ENVI.AS,NL,Envipco Holding N.V.,EUR,EQUITY,AMS,Industrials,Pollution & Treatment Controls,2024-05-15,5.80000019073486,5.80000019073486,2024-05-15,5.80000019073486,5.80000019073486,17,98.6000032424927,98.6000032424927,1.67603432587419,1.67603432587419 EVISO.MI,EVISO.MI,IT,eVISO S.p.A.,EUR,EQUITY,MIL,Utilities,Utilities—Regulated Electric,2024-05-15,4.90999984741211,4.90999984741211,2024-05-15,4.90999984741211,4.90999984741211,20,98.1999969482422,98.1999969482422,1.86293823453707,1.86293823453707 FTC.L,FTC.L,GB,Filtronic plc,GBp,EQUITY,LSE,Technology,Communication Equipment,2024-05-15,58.5,0.682131213331186,2024-05-15,58.5,0.682131213331186,147,8599.5,100.273288359684,2.925,0.0340851321595671 GAMC.O,GAMC,US,Golden Arrow Merger Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.0299997329712,10.1430884844427,2024-05-15,11.0299997329712,10.1430884844427,10,110.299997329712,101.430884844427,10.1468770873948,9.33296563558359 IDR.MC,IDR.MC,ES,"Indra Sistemas, S.A.",EUR,EQUITY,MCE,Technology,Information Technology Services,2024-05-15,20.1200008392334,20.1200008392334,2024-05-15,20.1200008392334,20.1200008392334,5,100.600004196167,100.600004196167,10.8941912325836,10.8941912325836 IGIC.O,IGIC,US,International General Insurance Holdings Ltd.,USD,EQUITY,NCM,Financial Services,Insurance—Diversified,2024-05-15,14.6700000762939,13.4904000401592,2024-05-15,14.6700000762939,13.4904000401592,7,102.690000534058,94.4328002811146,9.30404677312841,8.55774126931546 III.L,III.L,GB,3i Group Ord,GBp,EQUITY,LSE,,,2024-05-15,2966,34.5846355340222,2024-05-15,2966,34.5846355340222,3,8898,103.753906602067,1447.85882812435,16.8719519675262 IQG.L,IQG.L,GB,IQGeo Group plc,GBp,EQUITY,LSE,Technology,Software—Application,2024-05-15,472,5.50369115713367,2024-05-15,472,5.50369115713367,18,8496,99.0664408284061,114.359449092067,1.33263484991398 IVN.TO,IVN.TO,CA,Ivanhoe Mines Ltd.,CAD,EQUITY,TOR,Basic Materials,Other Industrial Metals & Mining,2024-05-15,19.9300003051758,13.4577588652472,2024-05-15,19.9300003051758,13.4577588652472,7,139.51000213623,94.2043120567304,8.61605916585422,5.81407950639264 JAM.L,JAM.L,GB,JPMorgan American Ord,GBp,EQUITY,LSE,,,2024-05-15,987,11.5087779069723,2024-05-15,987,11.5087779069723,9,8883,103.579001162751,734.693023539479,8.56140471933505 KKR.N,KKR,US,KKR & Co. Inc.,USD,EQUITY,NYQ,Financial Services,Asset Management,2024-05-15,107.669998168945,99.0123612861786,2024-05-15,107.669998168945,99.0123612861786,1,107.669998168945,99.0123612861786,51.1494689660835,47.0466166119071 KMER.MI,KMER.MI,IT,KME Group S.p.A.,EUR,EQUITY,MIL,,,2024-05-15,1.55999994277954,1.55999994277954,2024-05-15,1.55999994277954,1.55999994277954,64,99.8399963378906,99.8399963378906,0.800465071994058,0.800465071994058 KRNL.O,KRNL,US,"Kernel Group Holdings, Inc.",USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,10.9200000762939,10.0419337901592,2024-05-15,10.9200000762939,10.0419337901592,10,109.200000762939,100.419337901592,10.269285944972,9.44555571146799 KURN.VX,KURN.SW,CH,Kuros Biosciences AG,CHF,EQUITY,EBS,Healthcare,Medical Devices,2024-05-15,8,8.17366088441458,2024-05-15,8,8.17366088441458,12,96,98.083930612975,0.530445807104744,0.540606867796476 L.TO,L.TO,CA,Loblaw Companies Limited,CAD,EQUITY,TOR,Consumer Defensive,Grocery Stores,2024-05-15,155.139999389648,104.758488217297,2024-05-15,155.139999389648,104.758488217297,1,155.139999389648,104.758488217297,108.795430497776,73.4146865370985 LDO.MI,LDO.MI,IT,Leonardo S.p.a.,EUR,EQUITY,MIL,Industrials,Aerospace & Defense,2024-05-15,22.5,22.5,2024-05-15,22.5,22.5,4,90,90,9.15905866550776,9.15905866550776 LMB.O,LMB,US,"Limbach Holdings, Inc.",USD,EQUITY,NCM,Industrials,Building Products & Equipment,2024-05-15,50.6599998474121,46.5864799196816,2024-05-15,50.6599998474121,46.5864799196816,2,101.319999694824,93.1729598393631,3.1283030409755,2.87737246914973 MEMS.EQ,MEMS.PA,FR,"MEMSCAP, S.A.",EUR,EQUITY,PAR,Technology,Semiconductor Equipment & Materials,2024-05-15,7.75,7.75,2024-05-15,7.75,7.75,13,100.75,100.75,1.24829618687214,1.24829618687214 MEPK.N,MER-PK,US,Merrill Lynch Capital Trust I GTD CAP 6.45%,USD,EQUITY,NYQ,,,2024-05-15,25.3899993896484,23.3484149287262,2024-05-15,25.3899993896484,23.3484149287262,4,101.559997558594,93.3936597149048,23.4660902117283,21.5838047175749 MIKN.VX,MIKN.SW,CH,Mikron Holding AG,CHF,EQUITY,EBS,Industrials,Specialty Industrial Machinery,2024-05-15,16.9500007629395,17.3179447783545,2024-05-15,16.9500007629395,17.3179447783545,6,101.700004577637,103.907668670127,10.1066015477761,10.3002005739888 MLI.N,MLI,US,"Mueller Industries, Inc.",USD,EQUITY,NYQ,Industrials,Metal Fabrication,2024-05-15,59.0800018310547,54.3294379638214,2024-05-15,59.0800018310547,54.3294379638214,2,118.160003662109,108.658875927643,28.864001244309,26.5487331124992 MOD.N,MOD,US,Modine Manufacturing Company,USD,EQUITY,NYQ,Consumer Cyclical,Auto Parts,2024-05-15,109.419998168945,100.621645536179,2024-05-15,109.419998168945,100.621645536179,1,109.419998168945,100.621645536179,5.47099990844727,5.03215459279099 MSI.L,MSI.L,GB,MS INTERNATIONAL plc,GBp,EQUITY,LSE,Industrials,Conglomerates,2024-05-15,995,11.6020608079407,2024-05-15,995,11.6020608079407,9,8955,104.418547271466,299.053984032638,3.48488703199915 NBST.O,NBST,US,Newbury Street Acquisition Corporation,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,10.8400001525879,9.96836658031845,2024-05-15,10.8400001525879,9.96836658031845,10,108.400001525879,99.6836658031845,10.203750702138,9.38527724706745 NGEX.TO,NGEX.TO,CA,NGEx Minerals Ltd.,CAD,EQUITY,TOR,Basic Materials,Other Industrial Metals & Mining,2024-05-15,9.57999992370606,6.46890752273802,2024-05-15,9.57999992370606,6.46890752273802,15,143.699998855591,97.0336128410703,0.478999996185303,0.323227128293172 OCAX.O,OCAX,US,OCA Acquisition Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.1750001907349,10.2764296003981,2024-05-15,11.1750001907349,10.2764296003981,10,111.750001907349,102.764296003981,10.3482390933432,9.51817579094888 OPXS.O,OPXS,US,"Optex Systems Holdings, Inc",USD,EQUITY,NCM,Industrials,Aerospace & Defense,2024-05-15,8.56999969482422,7.8808945893631,2024-05-15,8.56999969482422,7.8808945893631,13,111.409996032715,102.45162966172,1.37396433534202,1.26375453411123 OSG.N,OSG,US,"Overseas Shipholding Group, Inc.",USD,EQUITY,NYQ,Energy,Oil & Gas Midstream,2024-05-15,6.8899998664856,6.33598186722136,2024-05-15,6.8899998664856,6.33598186722136,16,110.23999786377,101.375709875542,3.08423975967902,2.83684363583589 PLMI.O,PLMI,US,Plum Acquisition Corp. I,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.1199998855591,10.2258518147612,2024-05-15,11.1199998855591,10.2258518147612,10,111.199998855591,102.258518147612,10.3122527077106,9.48507598126697 PMGM.O,PMGM,US,Priveterra Acquisition Corp. II,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.0500001907349,10.1614807253981,2024-05-15,11.0500001907349,10.1614807253981,10,110.500001907349,101.614807253981,10.4066804048251,9.57192934951286 PNL.L,PNL.L,GB,Personal Assets Ord,GBp,EQUITY,LSE,,,2024-05-15,490,5.7135776843125,2024-05-15,490,5.7135776843125,18,8820,102.844398317625,205.388023341194,2.39339416053909 PSH.L,PSH.L,GB,Pershing Square Holdings Ord,GBp,EQUITY,LSE,,,2024-05-15,4058,47.3177515162043,2024-05-15,4058,47.3177515162043,2,8116,94.6355030324087,2760.24210472501,32.1652023698986 PUB.EQ,PUB.PA,FR,Publicis Groupe S.A.,EUR,EQUITY,PAR,Communication Services,Advertising Agencies,2024-05-15,106.150001525879,106.150001525879,2024-05-15,106.150001525879,106.150001525879,1,106.150001525879,106.150001525879,62.7854557332542,62.7854557332542 PUCK.O,PUCK,US,Goal Acquisitions Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,10.8500003814697,9.97756270079613,2024-05-15,10.8500003814697,9.97756270079613,10,108.500003814697,99.7756270079613,10.2216440084575,9.40173527760708 PWS.MI,PWS.MI,IT,Powersoft S.p.A.,EUR,EQUITY,MIL,Technology,Consumer Electronics,2024-05-15,16.2000007629395,16.2000007629395,2024-05-15,16.2000007629395,16.2000007629395,6,97.2000045776367,97.2000045776367,3.72774791732638,3.72774791732638 QDRO.O,QDRO,US,Quadro Acquisition One Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.0500001907349,10.1614807253981,2024-05-15,11.0500001907349,10.1614807253981,10,110.500001907349,101.614807253981,10.2946317689515,9.46886847086858 RDNT.O,RDNT,US,"RadNet, Inc.",USD,EQUITY,NGM,Healthcare,Diagnostics & Research,2024-05-15,58.2400016784668,53.556981383503,2024-05-15,58.2400016784668,53.556981383503,2,116.480003356934,107.113962767006,19.3818445183282,17.8271686239796 REAX.O,REAX,US,The Real Brokerage Inc.,USD,EQUITY,NCM,Real Estate,Real Estate Services,2024-05-15,5,4.597955,2024-05-15,5,4.597955,22,110,101.15501,0.25,0.22994675 RNWH.L,RNWH.L,GB,Renew Holdings plc,GBp,EQUITY,LSE,Industrials,Engineering & Construction,2024-05-15,1054,12.2900222025824,2024-05-15,1054,12.2900222025824,8,8432,98.3201776206592,681.809806634346,7.94515465532326 RR.FRA,RRU.F,DE,Rolls-Royce Holdings plc,EUR,EQUITY,FRA,Industrials,Aerospace & Defense,2024-05-15,4.94899988174439,4.94899988174439,2024-05-15,4.94899988174439,4.94899988174439,20,98.9799976348877,98.9799976348877,1.15474766444009,1.15474766444009 SAB.MC,SAB.MC,ES,"Banco de Sabadell, S.A.",EUR,EQUITY,MCE,Financial Services,Banks—Diversified,2024-05-15,1.90400004386902,1.90400004386902,2024-05-15,1.90400004386902,1.90400004386902,53,100.912002325058,100.912002325058,0.770675500087932,0.770675500087932 SLAM.O,SLAM,US,Slam Corp.,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,11.0500001907349,10.1614807253981,2024-05-15,11.0500001907349,10.1614807253981,10,110.500001907349,101.614807253981,10.3152097299573,9.48779581188824 SMHN.EQ,SMHN.F,DE,SÜSS MicroTec SE,EUR,EQUITY,FRA,Technology,Semiconductor Equipment & Materials,2024-05-15,51.2999992370606,51.2999992370606,2024-05-15,51.2999992370606,51.2999992370606,2,102.599998474121,102.599998474121,12.952163633103,12.952163633103 SOL.MI,SOL.MI,IT,SOL S.p.A.,EUR,EQUITY,MIL,Basic Materials,Specialty Chemicals,2024-05-15,33.7000007629395,33.7000007629395,2024-05-15,33.7000007629395,33.7000007629395,3,101.100002288818,101.100002288818,20.3776094280299,20.3776094280299 SPIE.EQ,SPIE.PA,FR,SPIE SA,EUR,EQUITY,PAR,Industrials,Engineering & Construction,2024-05-15,36.2200012207031,36.2200012207031,2024-05-15,36.2200012207031,36.2200012207031,3,108.660003662109,108.660003662109,24.4525122007507,24.4525122007507 TAYD.O,TAYD,US,"Taylor Devices, Inc.",USD,EQUITY,NCM,Industrials,Specialty Industrial Machinery,2024-05-15,51.3800010681152,47.2485865622292,2024-05-15,51.3800010681152,47.2485865622292,2,102.76000213623,94.4971731244583,5.60221111549934,5.15284095529179 TDW.N,TDW,US,Tidewater Inc.,USD,EQUITY,NYQ,Energy,Oil & Gas Equipment & Services,2024-05-15,108.110000610352,99.4169835712738,2024-05-15,108.110000610352,99.4169835712738,1,108.110000610352,99.4169835712738,8.89739581168513,8.18370900144243 TRD.L,TRD.L,GB,Triad Group plc,GBp,EQUITY,LSE,Technology,Information Technology Services,2024-05-15,277,3.22992044602972,2024-05-15,277,3.22992044602972,31,8587,100.127533826921,79.9188268645001,0.931297017338134 TRMD.O,TRMD,US,TORM plc,USD,EQUITY,NMS,Energy,Oil & Gas Midstream,2024-05-15,38.0400009155273,34.9812424819107,2024-05-15,38.0400009155273,34.9812424819107,3,114.120002746582,104.943727445732,15.7437186157142,14.4808677143919 TVK.TO,TVK.TO,CA,TerraVest Industries Inc.,CAD,EQUITY,TOR,Energy,Oil & Gas Equipment & Services,2024-05-15,78.879997253418,53.26382167953,2024-05-15,78.879997253418,53.26382167953,2,157.759994506836,106.52764335906,11.8947657049186,8.02653651594938 TWLV.O,TWLV,US,Twelve Seas Investment Company II,USD,EQUITY,NCM,Financial Services,Shell Companies,2024-05-15,10.8000001907349,9.93158297539806,2024-05-15,10.8000001907349,9.93158297539806,10,108.000001907349,99.3158297539806,10.1645252912436,9.34919822405708 UCG.MI,UCG.MI,IT,UniCredit S.p.A.,EUR,EQUITY,MIL,Financial Services,Banks—Regional,2024-05-15,36.2799987792969,36.2799987792969,2024-05-15,36.2799987792969,36.2799987792969,3,108.839996337891,108.839996337891,12.8251828408082,12.8251828408082 UNI.MI,UNI.MI,IT,Unipol Gruppo S.p.A.,EUR,EQUITY,MIL,Financial Services,Insurance—Diversified,2024-05-15,8.90499973297119,8.90499973297119,2024-05-15,8.90499973297119,8.90499973297119,11,97.9549970626831,97.9549970626831,4.53438024653025,4.53438024653025 URB.TO,URB.TO,CA,Urbana Corporation,CAD,EQUITY,TOR,Financial Services,Asset Management,2024-05-15,5.48000001907349,3.70037720566862,2024-05-15,5.48000001907349,3.70037720566862,27,147.960000514984,99.9101845530527,4.01565374986276,2.70974580401818 USAP.O,USAP,US,"Universal Stainless & Alloy Products, Inc.",USD,EQUITY,NMS,Basic Materials,Steel,2024-05-15,33.7299995422363,31.0178040090447,2024-05-15,33.7299995422363,31.0178040090447,3,101.189998626709,93.0534120271339,4.8737430358326,4.48280548569936 VCTR.O,VCTR,US,"Victory Capital Holdings, Inc.",USD,EQUITY,NMS,Financial Services,Asset Management,2024-05-15,52.1399993896484,47.9474741787262,2024-05-15,52.1399993896484,47.9474741787262,2,104.279998779297,95.8949483574524,27.0128366318881,24.8460559671344 VIL.EQ,VIL.PA,FR,"VIEL & Cie, société anonyme",EUR,EQUITY,PAR,Financial Services,Capital Markets,2024-05-15,10.75,10.75,2024-05-15,10.75,10.75,9,96.75,96.75,6.6231134232085,6.6231134232085 VIRC.O,VIRC,US,Virco Mfg. Corporation,USD,EQUITY,NGM,Consumer Cyclical,"Furnishings, Fixtures & Appliances",2024-05-15,12.539999961853,11.5316711049204,2024-05-15,12.539999961853,11.5316711049204,9,112.859999656677,103.785039944284,3.04456100600394,2.80034763402935 VRRM.O,VRRM,US,Verra Mobility Corporation,USD,EQUITY,NCM,Industrials,Infrastructure Operations,2024-05-15,27.3700008392334,25.1692064417515,2024-05-15,27.3700008392334,25.1692064417515,4,109.480003356934,100.676825767006,16.7701237135648,15.4249417801286 VRT.N,VRT,US,Vertiv Holdings Co,USD,EQUITY,NYQ,Industrials,Electrical Equipment & Parts,2024-05-15,104.599998474121,96.1892171968155,2024-05-15,104.599998474121,96.1892171968155,1,104.599998474121,96.1892171968155,5.22999992370606,4.81048593982583 W7L.L,W7L.L,GB,Warpaint London PLC,GBp,EQUITY,LSE,Consumer Defensive,Household & Personal Products,2024-05-15,485,5.65527587120727,2024-05-15,485,5.65527587120727,18,8730,101.794965681731,135.801416078837,1.58249887675333 WBDR.MI,WBDR.MI,IT,Webuild S.p.A.,EUR,EQUITY,MIL,Industrials,Engineering & Construction,2024-05-15,12,12,2024-05-15,12,12,8,96,96,4.99051752358873,4.99051752358873 X.TO,X.TO,CA,TMX Group Limited,CAD,EQUITY,TOR,Financial Services,Financial Data & Stock Exchanges,2024-05-15,36.4900016784668,24.6399215284378,2024-05-15,36.4900016784668,24.6399215284378,4,145.960006713867,98.559686113751,26.7457532329108,18.0479187481398 XPO.N,XPO,US,"XPO, Inc.",USD,EQUITY,NYQ,Industrials,Trucking,2024-05-15,114.059997558594,104.888547214905,2024-05-15,114.059997558594,104.888547214905,1,114.059997558594,104.888547214905,39.8781619915872,36.679414983756 XPS.L,XPS.L,GB,XPS Pensions Group plc,GBp,EQUITY,LSE,Consumer Cyclical,Personal Services,2024-05-15,262,3.05501500671403,2024-05-15,262,3.05501500671403,33,8646,100.815495221563,159.626440432165,1.86013275839029 YU_.L,YU.L,GB,Yü Group PLC,GBp,EQUITY,LSE,Utilities,Utilities—Diversified,2024-05-15,1735,20.2307291475147,2024-05-15,1735,20.2307291475147,5,8675,101.153645737573,86.75,1.01090092815126 ZYE1.FRA,ZYE1.F,DE,Addiko Bank AG,EUR,EQUITY,FRA,Financial Services,Banks—Regional,2024-05-15,18.7999992370605,18.7999992370605,2024-05-15,18.7999992370605,18.7999992370605,5,93.9999961853027,93.9999961853027,11.4772920878681,11.4772920878681 MINIMUM,,,,,,,,,,,0.601674693453668,,,0.601674693453668,1,,90,,0.0340851321595671 MAXIMUM,,,,,,,,,,,106.150001525879,,,106.150001525879,166,,110,,73.4146865370985 MEDIAN,,,,,,,,,,,12.1450111012912,,,12.1450111012912,8,,100.214999198914,,8.08285630340646 AVERAGE,,,,,,,,,,,26.0156541478769,,,26.0156541478769,14.55,,99.965850856796,,10.7737737301551 TOTAL,,,,,,,,,,,2601.56541478769,,,2601.56541478769,1455,,9996.5850856796,,1077.37737301551 
submitted by Torre_Nera to investing [link] [comments]


2024.05.17 09:10 TerribleSell2997 Industrial Couplings Market Increasing Demand, Growth Analysis and Future Outlook by 2031

~Industrial couplings market~ is anticipated to grow at a considerable CAGR of 4.5% during the forecast period. The rising industrialization and adoption of the Industry 4.0 revolution across the globe have created the demand for an industrial coupling market. The high demand for industrial coupling from the end-user industry is a key factor driving the growth of the global industrial couplings market. To meet the growing demand for industrial couplings key players are expanding their production facilities. For instance, in July 2023, R+W, a global brand of precision couplings for motion control and automation systems, opened a new US-based manufacturing facility with expanded machining capabilities and assembly operations for its precision couplings and line shafts. The company relocated into the 30,000-square-foot facility in West Chicago, IL in late 2022, and is currently ramping up to produce the majority of its precision bellows couplings, elastomer couplings, and line shafts for the North American market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/industrial-couplings-market
The global industrial couplings market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, Asia-Pacific is estimated to be the fastest-growing region owing to the growing industrialization in emerging economies such as India & China. Government initiatives, such as the 'Make in India' and ‘Made in China’ programs, have further strengthened the place of the region in the industrial coupling market. The growing automobile industry is further driving the demand for the industrial coupling market.?
full report of Industrial Couplings Market available @ https://www.omrglobal.com/industry-reports/industrial-couplings-market
· Market Coverage
· Market number available for – 2024-2031
· Base year- 2024
· Forecast period- 2024-2031
· Segment Covered- By Source, By Product Type, By Applications
· Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
· Inc., and others
Market Segmentation
Global Industrial Couplings Market by Type
o Flexible Coupling
o Rigid Coupling
Global Industrial Couplings Market by End-User
o Automotive
o Healthcare
o Aerospace & Defense
o Oil and Gas
o Metal and Mining
o Other
Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
o Rest of the World
Company Profiles
o Baldor Electric (ABB Ltd)
o Colossus
o Daido Precision Industries Ltd.
o Dandong Colossus Group Co. Ltd.
o Dhara Industries
o Elegant Engineering Corp.
o Emerson Electric Co.
o Industrial Clutch Parts Ltd.
o John Crane Ltd.
o KK Foundry
o KTR Systems
o Nishi Enterprise
o Premium Energy Transmission Ltd.
o Rexnord Corp.
o Sedan Engineering Enterprises
o Shri Umiya Industries
o Tsubakimoto Chain
o Summit Tools Corp.
o SuperMech Industries
o Utkur Iron & Steel Industries
o Wiperdrive Industries
The Report Covers
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/industrial-couplings-market
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [info@omrglobal.com](mailto:info@omrglobal.com)
Contact no: +91 780-304-0404
submitted by TerribleSell2997 to Nim2908 [link] [comments]


2024.05.17 09:00 TerribleSell2997 Tow Tractor Market Increasing Demand, Growth Analysis and Future Outlook by 2031

~Tow tractor market~ is anticipated to grow at a CAGR of 3.5% during the forecast period (2024-2031). Tow tractors are energy-efficient vehicles that are used in the transportation of goods and loads in warehouses, distribution centers, industries, and several other places. Towing tractors offer safety and high efficiency for picking and transportation operations of various types of goods such as stacked goods or unstacked goods, and roller caged goods.
Get Free Sample link @ https://www.omrglobal.com/request-sample/tow-tractor-market
Rise in awareness about environmental protection across the globe and enactment of stringent emission norms are the major factors boosting the adoption of electric tow tractors. Preference for these tractors are increasing in the industrial application for material handling operations due to advantages such as environmental friendliness, cost-effectiveness, enhanced efficiency & productivity, noise reduction, flexibility, and adaptability. The tow tractor industry is experiencing substantial growth, propelled by a heightened emphasis on sustainability, particularly through the widespread adoption of eco-friendly power sources such as lithium-ion batteries. As industries prioritize environmental considerations, the shift towards cleaner energy solutions aligns with eco-conscious practices and positions tow tractors as integral components in the evolving landscape of sustainable material handling, driving their increased demand and market growth.
full report of Tow Tractor Market available @ https://www.omrglobal.com/industry-reports/tow-tractor-market
· Market Coverage
· Market number available for – 2024-2031
· Base year- 2024
· Forecast period- 2024-2031
· Segment Covered- By Source, By Product Type, By Applications
· Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
· Inc., and others
Market Segmentation
Global Tow Tractor Market by Type
o Rider-Seated Towing Tractor
o Stand-in Towing Tractor
o Pedestrian Towing Tractor
Global Tow Tractor Market by Propulsion
o Electric
o Fuel
Global Tow Tractor Market by Application
o Airports
o Railway Stations
o Supermarkets
o Industries
o Warehouses
Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
o Rest of the World
Company Profiles
o Alke s.r.l
o Eagle Tugs
o Helge Nyberg AB
o John Bradshaw Ltd.
o Kalmar Motor AB
o KION GROUP AG
o Komatsu
o Linde Material Handling GmbH
o Mitsubishi Logisnext Co., Ltd.
o Motrec International Inc.
o SIMAI S.p.A
o Stanley Black & Decker, Inc.
o Taylor-Dunn Manufacturing, LLC
o The Raymond Corp.
o Toyota Material Handling, Inc.
The Report Covers
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tow-tractor-market
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [info@omrglobal.com](mailto:info@omrglobal.com)
Contact no: +91 780-304-0404
submitted by TerribleSell2997 to Nim2908 [link] [comments]


2024.05.17 08:37 TerribleSell2997 North American Optical Interconnect Market is Dazzling Worldwide and Forecast to 2030

The ~North American optical interconnect market~ is estimated to grow at a CAGR of around 11.5% during the forecast period. North American Optical Interconnect Market report provides us with a complete outlook on thorough assessment of thorough data about vital feature of the global industry related to market size, revenue, development and market sales. This study report captures regulatory concerns and entry barriers that greatly affect the market growth. This report emphasizes on how industries get benefit from strategies offered here and achieve ample revenue other than also flashes light on constraints which can become great obstruction. It further helps to predict revenue increasing opportunities available in the marketplace. In addition, it then goes on to talk about volume trends, values and historical pricing structure. This North American Optical Interconnect Market study report also helps to predict growth and opportunities in the market. Furthermore, it also guides on how to increase product demand, growth rate and gain huge profits through changing consumption technologies.
Get Free Sample link @ https://www.omrglobal.com/request-sample/north-american-optical-interconnect-market
The companies which are contributing to the growth of the North American optical interconnect market include II-VI Inc., Broadcom Inc., Intel Corp., NVIDIA Corp., Corning Inc., Infinera Corp., and others. Product launch, merger, and acquisition, collaborations with government, and technological advancements through which market players are considerably contributing to the market growth to stay competitive in the market.
full report of North American Optical Interconnect Market available @ https://www.omrglobal.com/industry-reports/north-american-optical-interconnect-market
· Market Coverage
· Market number available for – 2024-2031
· Base year- 2024
· Forecast period- 2024-2031
· Segment Covered- By Source, By Product Type, By Applications
· Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
· Inc., and others
North American Optical Interconnect Market – Segmentation
By Product Type
By Application
North American Optical Interconnect Market – Segmentation by Region
The Report Covers
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/north-american-optical-interconnect-market
About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [info@omrglobal.com](mailto:info@omrglobal.com)
Contact no: +91 780-304-0404
submitted by TerribleSell2997 to Nim2908 [link] [comments]


2024.05.17 08:13 Head-Badger-6377 how long is too long to apply again after B2 rejection?

I, 23 F, single pakistani, resident of the UAE, went to my B2 visa interview today and got rejected with a 214 (b). Everything seemed to be going fine with the interview until I mentioned I had just graduated from med school but am currently working in Pakistan as a house officer and plan to specialize further there so that she knew I had full intentions of going back but I got rejected ): How long do you think I should wait before reapplying? And what do you think I could do to help my application? and would any of you recommend for me to go to a travel agent and get help w preparing to apply again?
I also have a travel history to Greece and the UK in march this year and mentioned I would like to just visit LA and visit the attractions there, but she wasn’t too convinced lmao. i was also dressed well and have a slight american accent i don’t know if that threw her off please let me know. thank youu
submitted by Head-Badger-6377 to immigration [link] [comments]


2024.05.17 08:08 prajnene Agriculture Drone Market Size Trends, Growth, and Competitive Landscape

According to a report by Fortune Business Insights titled "Agriculture Drone Market Size, 2024-2030," the global agriculture drone market was valued at USD 4.17 billion in 2022. The market is expected to grow from USD 4.98 billion in 2023 to USD 18.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.3% during the forecast period. Agriculture drones, which are Unmanned Aerial Vehicles (UAVs) specifically designed for farming and agricultural applications, are equipped with advanced imaging technologies and sensors such as LiDAR, cameras, and multispectral sensors. These technologies enable the drones to collect data on soil, crops, and other factors that influence agricultural production.
~List of Key Players Mentioned in the Report:~
~Browse In-depth Summary of This Research Insight:~
https://www.fortunebusinessinsights.com/agriculture-drones-market-102589
~Segments:~
Rotary Drone Segment to Dominate Due to Improved Structural Benefits
Based on type, the market is split into fixed wing, rotary wing, and hybrid. Among these, the rotary wing segment captured the largest agriculture drone market share in 2022. Rotary wing drones are available in a variety of designs and sizes. The enhanced structural benefits of the segment are aiding growth of this segment.
Hardware Segment to Lead Stoked by the Improved Ability to Collect and Process Data
As per component, the agriculture drone market is bifurcated into hardware and software. The hardware segment held majority of the global market share in 2022 owing to the improved capability of hardware components to collect and process the data and enable farmers to make informed decisions.
Frames Segment to Hold Major Share Due to Surging Demand for Robust Frame Structures
According to hardware, the market is divided into frames, control systems, propulsion systems, navigation systems, payload, avionics and others. Among these, the frame segment captured a significant market share in 2022 backed by the rising need for robust frames to support the drone’s hardware components, Moreover, industry leaders are focused on producing non-breakable frames, further aiding segment growth.
Imaging Software Segment to Capture Largest Share Due to its Ability to Help in Quick Problem Solving
The market by software is arrayed into imaging software, data management software, data analytics software, and others. Imaging software segment held the largest market share in 2022 as it enables the operator to detect and respond to the potential problems early, thus decreasing the risk of crop loss and improving yields.
Field Mapping & Monitoring Segment to Lead Due to Availability of Better Equipment
By application, the market is segregated into field mapping & monitoring, crop spraying, crop scouting, variable rate application, livestock monitoring, and others. The field mapping & monitoring segment dominated the market in 2022 owing to the availability of better high-tech camera equipment to monitor crops.
Geographically, the agriculture drone market is segregated North America, Europe, Asia Pacific, and the Rest of the World.
~Drivers and Restraints: Agriculture Drone Market Size~
Rising Support by Various Governments for Agriculture Drones to Propel Market Expansion
Governments across the world are announcing several policies and initiatives to support agriculture drone adoption. This includes R&D grants, tax incentives, subsides, regulatory frameworks, training and education, and others. For instance, in April 2022, the U.S. Department of Agriculture received a grant for USD 1 million for innovations in digital agriculture. By providing regulatory and financial support, governments are helping to make UAVs more accessible to farmers while also ensuring that they are used in a safe and responsible way.
On the other hand, concerns regarding data overload and inaccuracies in collected data due to hardware or software issues and environmental factors will pose as challenges for businesses operating in this domain.
~Regional Insights:~
Europe to Hold Largest Share Backed by Strong Research and Development Facilities
Europe captured a significant global market share in 2022 owing to the surging demand for the drones, rising funding, and strong research and development capabilities of the region. Moreover, the growing number of startups such as Gamaya, Delair, Accelerated Dynamics, and others will further aid regional market expansion.
Meanwhile, Asia Pacific is projected to record the highest growth rate in the forecast timeframe due to presence of large agricultural countries such as India, Indonesia, China, and others. The rising demand for UAVs from these countries and growing focus of market players on developing advanced products will further facilitate regional market expansion.
~Competitive Landscape:~
Innovative Product Launches by Leading Companies to Drive Market Expansion
Industry leaders usually make tactical moves such as collaborations, partnerships, mergers and acquisitions, and product launches to hold a dominant share in the global market. For example, in November 2021, XAG announced its plans to launch its P40 and V40 agricultural drones worldwide, thus bringing digital agriculture to rural areas with geriatric populations and poor infrastructure. The XAG V40 and P40 are fully autonomous drones capable of mapping, spraying, and farm broadcasting.
~Key Industry Development: Agriculture Drone Market Size~
March 2023 – Avikus and Korea Shipbuilding & Offshore Engineering, a subsidiary of Hyundai, entered into an agreement to carry out an experiment on fuel efficiency by implementing self-governing navigation systems. The venture incorporates five firms, Pan Ocean, POS SM, Korea Shipbuilding & Offshore Engineering, Avikus, and Korean Register of Shipping.
submitted by prajnene to u/prajnene [link] [comments]


2024.05.17 07:14 zksoapss Asian Male CS um rejected um Stanford um MIT um Bay Area + High Income

Demographics
Intended Major(s): CSCSCSCSCSCS
Academics
Standardized Testing
List the highest scores earned and all scores that were reported.
Extracurriculars/Activities
List all extracurricular involvements, including leadership roles, time commitments, major achievements, etc.
  1. President of School Robotics Club (Leadership)
  2. *Internship at Apple: (*worked on apple vision pro for a few years, currently helping on confidential unreleased product)
  3. Ebook with roughly 100 million sales
  4. AI startup company gone public with a market cap of ~$2,000,000,000 (all profits invested into my nonprofit foundation)
  5. Nonprofit volunteer organization lifting roughly 3 million Africans out of poverty per year
  6. Published research coauthored with Elon Musk with ~400 citations
  7. Other nonprofit organization helping install 100,000 solar panels in my community
  8. Made a deal with the President of Egypt to claim the narrow strip of land between Egypt and Sudan and turn it into a sovereign country. ~30 skyscrapers built and 2 McDonalds opened. Currently working out negotiations with major retailers to open stores in the region
  9. Spoke with Greta Thunberg at COP28 (spent 5 hrs/day for 2 weeks drafting the speech)
  10. Formally secured peace between Israel and Palestine by brokering a peace deal (2 hrs/week for 4 weeks)
  11. Internship at NASA, currently have a key role in the Artemis Moon Landing (No spoilers!)
Awards/Honors
List all awards and honors submitted on your application.
  1. National Merit Finalist
  2. National Spanish Exam Gold
  3. AP Scholar with Distinction
  4. AP Capstone Diploma
  5. Honor Role in my school for maintaining 4.0 GPA weighted
  6. Congressional App Challenge best in District
  7. Google Code Jam winner
  8. Apple Swift Student Developer Challenge winner
  9. IOI contestant
  10. ISEF winner
  11. IPho qual
  12. IMO winner
  13. IAO winner
  14. IEO winner
  15. also IOL qual but who cares about that
Letters of Recommendation
AP CS teacher (7/10) participated in his class a lot and was attentive. Appreciated my work ethic but was skeptical about me being qualified for HYPSM.
APush teacher (10/10) We often talked about American politics and historical events and I know he was a big fan of me, also sponsored one of my clubs)
Discrete Mathematics Teacher (10/10) Was fascinated by my work on the Riemann Hypothesis, and we coauthored dozens of papers together.
Interviews
MIT - Awful, the interviewer clearly stated that I needed to be more well rounded and gain more perspective before trying to enter into a competitive school like MIT. He said he would make sure that I never end up within 10 miles of MIT campus.
Stanford - Decent, talked about my accomplishments and we went to the same high school, so we talked a bit about that. But he expressed similar concerns about me being the right fit for a top notch school like Stanford
Essays
They seemed very good, my parents paid for a service to write them for me.
Decisions (indicate ED/EA/REA/SCEA/RD)
Acceptances:
Waitlists:
Rejections:
Thoughts:
Kinda bummed about the MIT and Stanford rejections, but I guess that's what comes with being an average high income CS majoring Bay Area asian male. But Berkeley EECS is still a great program, and I'm lucky to be accepted to it to pursue my dreams of working for google 😁.
submitted by zksoapss to collegeresults [link] [comments]


2024.05.17 06:26 Pilot9288 French Embassy in Amman, Jordan

Today, on May 1st, 2024, I accompanied my Russian wife and our 3- and 4-year-old daughters to submit a visa application at the French Embassy via the TLScontact office in Amman, Jordan.
I booked a prime-time appointment through the LTScontact website, costing 45 JD, along with a service fee of 24 JD.
Upon arrival, I informed the staff at the main entrance that my daughters and I hold American passports. I completed the application for my Russian wife, who is not fluent in Arabic or English. I intended to assist with translation.
Regrettably, we were denied entry to the LTScontact office located in Amman Jordan, including my young daughters. Inside, we overheard comments suggesting our American citizenship made us unwelcome due to the United States’ support for Israel in the conflict with Gaza.
Is such treatment acceptable for American citizens by LTScontact?
After persistent efforts and discussions at the gate, a staff member contacted the LTScontact supervisor. I made it clear that if our entry was refused due to our American citizenship, we would withdraw our visa application for my Russian wife. Finally, after numerous attempts, approval was granted, albeit amidst significant hostility.
My wife previously held a French Schengen visa, along with other European multi-entry visas.
This treatment from LTScontact management in Amman, Jordan, is unacceptable. We are not involved in American support for the Gaza conflict and do not interfere in US foreign policies.
Such behavior from LTScontact is disgraceful, reflecting poorly on the French embassy in Amman.
———————————————-
Aujourd'hui, le 1er mai 2024, j'ai accompagné ma femme russe et nos filles âgées de 3 et 4 ans pour soumettre une demande de visa à l'Ambassade de France via le bureau TLScontact à Amman, en Jordanie.
J'ai réservé un rendez-vous en heure de pointe via le site web de LTScontact, pour un coût de 45 JD, ainsi qu'une taxe de service de 24 JD.
À notre arrivée, j'ai informé le personnel à l'entrée principale que mes filles et moi détenions des passeports américains. J'ai rempli la demande pour ma femme russe, qui ne parle pas couramment l'arabe ni l'anglais. J'avais l'intention d'assister à la traduction.
Regrettant, nous nous sommes vu refuser l'entrée au bureau de LTScontact situé à Amman, en Jordanie, y compris mes jeunes filles. À l'intérieur, nous avons entendu des commentaires suggérant que notre citoyenneté américaine nous rendait indésirables en raison du soutien des États-Unis à Israël dans le conflit avec Gaza.
Un tel traitement est-il acceptable pour les citoyens américains par LTScontact ?
Après des efforts persistants et des discussions à la porte, un membre du personnel a contacté le superviseur de LTScontact. J'ai clairement indiqué que si notre entrée était refusée en raison de notre citoyenneté américaine, nous retirerions notre demande de visa pour ma femme russe. Finalement, après de nombreuses tentatives, l'approbation a été accordée, bien que dans un contexte de grande hostilité.
Ma femme détenait précédemment un visa Schengen français, ainsi que d'autres visas à entrées multiples européens.
Ce traitement de la part de la direction de LTScontact à Amman, en Jordanie, est inacceptable. Nous ne sommes pas impliqués dans le soutien américain au conflit de Gaza et n'interférons pas dans les politiques étrangères des États-Unis.
Un tel comportement de la part de LTScontact est honteux et ternit l'image de l'ambassade de France à Amman.
submitted by Pilot9288 to SchengenVisa [link] [comments]


2024.05.17 05:58 Proper-Community-465 How would the world react if Israel followed the law to the letter regarding aid?

From what I'm reading and understanding Israel isn't actually required to allow aid in to Gaza at least not anywhere near the level it currently does. They could effectively stop providing or allowing food entirely if they chose and without breaking any laws due Hamas and other groups stealing aid. Even without the issue's of stealing aid they are only required to provide it to children and pregnant women under international law and the burden is on the one providing the aid to distribute it and ensure it only goes to those people. How would the world react if rather then invading Rafah they simply cut off aid or STRICTLY controlled it for only pregnant women and children and actually forced a civilian evacuation so they could deal with the tunnels? This could also work from a PR perspective to show the consequences of Hamas committing war crimes by stealing the aid. And could help dodge the issue of using American weapons in Rafah or the invasion as a whole while helping to push for a proper evacuation in a safe zone. The relevant law requiring aid to civilians in wartime is from Article 23 of the Geneva convention 1949 and specifies the food is for children under 15 and expecting mothers specifically, Additionally there are several exceptions where food can be stopped , That it be diverted from its destination, Control (Distrubition) is not effective, Or a military advantage can be gained or the economy of the enemy benefitted. The 1977 Ap article 69 I also touches on the this subject BUT neither Israel nor the united states is a signatory, It also ONLY applies to occupying powers which Israel is not in regards to Gaza.
shoutout to CreativeRealmsMC for pointing this out in "Do you support the stopping of stripping of aid trucks?" https://ihl-databases.icrc.org/en/ihl-treaties/api-1977/article-69
https://ihl-databases.icrc.org/en/ihl-treaties/gciv-1949/article-23
https://lieber.westpoint.edu/applicability-article-23-fourth-geneva-convention-gaza/#:\~:text=Of%20considerable%20importance%2C%20Article%2023,to%20effectively%20supervise%20its%20distribution.
submitted by Proper-Community-465 to IsraelPalestine [link] [comments]


2024.05.17 05:26 ClearBucket Need Some Info and Opinion

We applied for my wife, I’m American and she’s Armenian, about a year ago and they processed it from June 2023. I know the estimate on the USCIS dashboard doesn’t mean much but it went from 1 week to 4 months to 2 months to 23 months.
The application was done from Armenia. I had to get a new job which now requires me to be in the IS 50 weeks a year when not on PTO.
She is currently here on a B1/B2 VISa and must leave by July 5th 2024.
Are we really expected to spend 2 years apart or do we have other reasonable options? Thanks in advance for any options and advice!
Field Office: California Service Center
submitted by ClearBucket to USCIS [link] [comments]


2024.05.17 05:03 DreamOfV Unauthorized inquiries have me worried

Today, I noticed I had a new inquiry on my TransUnion report as of yesterday from a random credit union I’ve never done business with. I called them and they confirmed “I” applied for a card with them yesterday with my personal information.
They reported it to their fraud department and I froze my credit at the three bureaus. Looking at my reports again, there was an inquiry last week (May 8) from American Express on my TransUnion report that I didn’t make either. I applied for an AmEx card on April 4 and got an inquiry on my Experian report that day, and sometimes when a card pulls multiple bureaus one of them is a little later. Is it possible the May 8 pull was just remaining from the April 4 card application, or was this also fraud?
General tips on what to do next?
submitted by DreamOfV to CRedit [link] [comments]


2024.05.17 05:02 eezom Will Using Incorrect Australian Spelling Impact My Job Chances?

Hey everyone,
I have recently applied for a job, and I've noticed that I've used the American spelling "inquiries" instead of the Australian spelling "enquiries" in my application when talking about web traffic. I used ChatGPT and Grammary to check over before applying, and it changed the word "enquiries" to inquiries".
I'm concerned that this might reflect poorly on my attention to detail and kicking myself that I checked my cover letter a few days later and picked this up.
Do you think using the incorrect Australian spelling could negatively impact my chances of getting the job? Should I try to correct it? Or would it be better to leave it as is and hope it's not a big deal?
Thanks in advance for any advice or insights you can offer!
submitted by eezom to Careers [link] [comments]


2024.05.17 04:39 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to Censored_Psychology [link] [comments]


2024.05.17 04:38 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to radicalmentalhealth [link] [comments]


2024.05.17 04:37 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to SurvivorPsychiatry [link] [comments]


2024.05.17 04:36 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to PsychiatryDAO [link] [comments]


2024.05.17 04:35 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to DebatePsychiatry [link] [comments]


2024.05.17 04:33 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to criticalpsychiatry [link] [comments]


2024.05.17 04:31 Perlanterna Psychiatry rescued by pharmaceuticals

Psychiatry's crisis of legitimacy in the 60s and 70s was a demand for accountability. Where was the science? The results?
"The Medical Director of the APA at the time, Melvin Sabshin, recalls that private insurance companies and the federal government began to view psychiatry as a "'bottomless pit-a voracious consumer-of resources and insurance dollars-because its methods of assessment and treatment were too fluid and unstandardized." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Its reputation in tatters, from 1965 to 1972 National Institute of Mental Health funding for psychiatric research decreased at a rate of 5% per year.
There were voices that had warned against this helter-skelter thrusting of psychiatry onto an international stage:
The subject's greatest benefactor, the Rockefeller Foundation, knew very well that neither biological nor dynamic psychiatry had any actual scientific foundation and were astonished at what was going on. https://perlanterna.com/#social-racket
Others in the profession described what was occurring. From an article from psychiatrist Roy R Grinker in 1965: "There is a ferment to displace attention from the individual to larger groups and even to the world to prevent war and to facilitate social and cultural change. Unfortunately, extension of an activity is not a substitute for research or knowledge." Mitchell Wilson MD. 1990 DSM III and the Transformation of American Psychiatry: A History.
Despite these and other warning voices, no one listened. Psychiatry was on a fast train to nowhere. What would save it?
What did, had nothing to do with psychiatric 'knowledge'. In 1950 a tranquilizer of peculiar properties was found by chance to hide the symptoms of what psychiatry said to be 'mental illness'. Its use within psychiatry was driven by pharmaceutical company marketing over decades until it eclipsed most other psychiatric clinical applications, making the manufacturers previously unheard-of fortunes in profits. The pharmaceutical industry now determined psychiatric 'treatment'. The pharmaceutical industry domination of psychiatry had begun.
https://perlanterna.com/psychiatry-saved
submitted by Perlanterna to Antipsychlibrary [link] [comments]


http://rodzice.org/